Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Nov
12
2014
California Life Science Company Pays $55 Million in FCPA (Foreign Corrupt Practices Act) Settlement Steptoe & Johnson PLLC
Jun
24
2019
Historic Vote in Congress Aims to Protect State Cannabis Programs Steptoe & Johnson PLLC
Jul
28
2016
Medical Marijuana in Pennsylvania: Employers Should Prepare for Accelerated MMA Program Implementation Steptoe & Johnson PLLC
Mar
17
2017
Drug Enforcement Administration Addition Of Marijuana Extracts To Schedule I Substance Category Sheds Light On The Ever-Expanding Arena Of Drugs In The Workforce Steptoe & Johnson PLLC
Aug
2
2017
Do You Pass the Test? New Safer Workplaces Act Expands and Limits Drug and Alcohol Testing Steptoe & Johnson PLLC
Aug
14
2018
Talc Defendant to Appeal Recent Missouri Verdict Steptoe & Johnson PLLC
Jan
28
2020
EPA Lists 160 PFAS for EPCRA Toxics Release Reporting Steptoe & Johnson PLLC
Mar
16
2015
Biometric Time Keeping - Replacing Traditional Time Card Machines Steptoe & Johnson PLLC
Jul
29
2019
Senate Holds Public Hearing on Banking Access for the Cannabis Industry Steptoe & Johnson PLLC
Apr
9
2011
Climate Facts and Fancy: From God to Cows, Facts and Falsehoods Accompany Global Warming Votes Center for Public Integrity
Oct
1
2011
Solyndra Executives Refusing to Answer Bankruptcy Questions Center for Public Integrity
Jan
3
2011
EPA Reminds Republicans Cap-and-Trade Used to be GOP Idea — and it Worked for Acid Rain Center for Public Integrity
Oct
4
2011
Donor Warned Obama that Solyndra 'could haunt him' Center for Public Integrity
Jan
30
2012
Loophole in Senate Bill May Create Nuclear Risks Center for Public Integrity
Aug
17
2011
Green Groups Challenge EPA's Air Pollution Exemption for Biomass Power Plants Center for Public Integrity
Jul
25
2012
Pollution Pact in Wisconsin: U.S. EPA Issues Fines, Orders Upgrades at Coal-Fired Power Plants Center for Public Integrity
Mar
17
2011
While Touting Green Power, Democrats Arrange Duke Energy Backup Loan Center for Public Integrity
Oct
31
2011
GOP to Subpoena White House over Solyndra Center for Public Integrity
Apr
30
2011
Coal is Back, Even as the Obama Administration Pushes Green Energy Center for Public Integrity
May
8
2011
National Biomass Debate Intensifies With New Limits in Massachusetts Center for Public Integrity
Feb
5
2011
‘Clean Energy’ Expansion Could Strain U.S. Power Grid Center for Public Integrity
Sep
1
2011
Obama-backed Solar Firm Collapses After A Big Federal Loan Guarantee Center for Public Integrity
Sep
8
2011
Congressional Hearing to Focus on Obama Administration Loan to Failed Energy Firm Center for Public Integrity
May
11
2011
Newt Gingrich Faces Questions About Consulting Job and Support for Biofuels Center for Public Integrity
Jul
24
2011
Office of Management and Budget Dodges Subpoena on Solyndra Center for Public Integrity
Sep
11
2011
Solyndra Investigation Expands as Agents Visit Executives’ Homes Center for Public Integrity
Sep
16
2011
GOP Demands Investigation into LightSquared Contacts with White House Center for Public Integrity
Jun
1
2015
In Affirming a Preliminary Injunction Against Drug Companies, Second Circuit Finds Coercion in Product Hopping Scheme American University Washington College of Law
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins